Clinical Trial Update: A Study of MT027 in Patients with Pleural Malignant Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating MT027 in patients with pleural malignant tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Pleural Mesothelioma
• Pleural Metastases

Drugs mentioned

• MT027

Snippet

Sponsor: Suzhou Maximum Bio-tech Co., Ltd. | Conditions: Advanced Malignant Solid Tumor, Malignant Pleural Effusion | Phase 1 | Status: RECRUITING